Literature DB >> 16861624

IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri.

Marianela Espina1, Andrew J Olive, Roma Kenjale, David S Moore, S Fernando Ausar, Robert W Kaminski, Edwin V Oaks, C Russell Middaugh, William D Picking, Wendy L Picking.   

Abstract

Shigella flexneri, the causative agent of shigellosis, is a gram-negative bacterial pathogen that initiates infection by invading cells within the colonic epithelium. Contact with host cell surfaces induces a rapid burst of protein secretion via the Shigella type III secretion system (TTSS). The first proteins secreted are IpaD, IpaB, and IpaC, with IpaB and IpaC being inserted into the host cell membrane to form a pore for translocating late effectors into the target cell cytoplasm. The resulting pathogen-host cross talk results in localized actin polymerization, membrane ruffling, and, ultimately, pathogen entry. IpaD is essential for host cell invasion, but its role in this process is just now coming to light. IpaD is a multifunctional protein that controls the secretion and presentation of IpaB and IpaC at the pathogen-host interface. We show here that antibodies recognizing the surface-exposed N terminus of IpaD neutralize Shigella's ability to promote pore formation in erythrocyte membranes. We further show that MxiH and IpaD colocalize on the bacterial surface. When TTSS needles were sheared from the Shigella surface, IpaD was found at only the needle tips. Consistent with this, IpaD localized to the exposed tips of needles that were still attached to the bacterium. Molecular analyses then showed that the IpaD C terminus is required for this surface localization and function. Furthermore, mutations that prevent IpaD surface localization also eliminate all IpaD-related functions. Thus, this study demonstrates that IpaD localizes to the TTSA needle tip, where it functions to control the secretion and proper insertion of translocators into host cell membranes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861624      PMCID: PMC1539624          DOI: 10.1128/IAI.00440-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells.

Authors:  G Tran Van Nhieu; E Caron; A Hall; P J Sansonetti
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Optimization of virulence functions through glucosylation of Shigella LPS.

Authors:  Nicholas P West; Philippe Sansonetti; Joëlle Mounier; Rachel M Exley; Claude Parsot; Stéphanie Guadagnini; Marie-Christine Prévost; Ada Prochnicka-Chalufour; Muriel Delepierre; Myriam Tanguy; Christoph M Tang
Journal:  Science       Date:  2005-02-25       Impact factor: 47.728

3.  The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.

Authors:  Catherine A Mueller; Petr Broz; Shirley A Müller; Philippe Ringler; Françoise Erne-Brand; Isabel Sorg; Marina Kuhn; Andreas Engel; Guy R Cornelis
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

4.  Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes.

Authors:  Julien Goure; Petr Broz; Olivier Attree; Guy R Cornelis; Ina Attree
Journal:  J Infect Dis       Date:  2005-06-07       Impact factor: 5.226

5.  Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).

Authors:  K R Turbyfill; J A Mertz; C P Mallett; E V Oaks
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Virulence role of V antigen of Yersinia pestis at the bacterial surface.

Authors:  K A Fields; M L Nilles; C Cowan; S C Straley
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.

Authors:  Wendy L Picking; Hiroaki Nishioka; Patricia D Hearn; M Aaron Baxter; Amanda T Harrington; Ariel Blocker; William D Picking
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Interaction of Shigella flexneri IpaC with model membranes correlates with effects on cultured cells.

Authors:  N Tran; A B Serfis; J C Osiecki; W L Picking; L Coye; R Davis; W D Picking
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 9.  Mechanism of Shigella entry into epithelial cells.

Authors:  G T Nhieu; P J Sansonetti
Journal:  Curr Opin Microbiol       Date:  1999-02       Impact factor: 7.934

10.  The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes.

Authors:  A Blocker; P Gounon; E Larquet; K Niebuhr; V Cabiaux; C Parsot; P Sansonetti
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

View more
  92 in total

Review 1.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

Review 2.  The blueprint of the type-3 injectisome.

Authors:  Agata Kosarewicz; Lisa Königsmaier; Thomas C Marlovits
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-04-19       Impact factor: 6.237

Review 3.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Protein refolding is required for assembly of the type three secretion needle.

Authors:  Omer Poyraz; Holger Schmidt; Karsten Seidel; Friedmar Delissen; Christian Ader; Hezi Tenenboim; Christian Goosmann; Britta Laube; Andreas F Thünemann; Arturo Zychlinsky; Marc Baldus; Adam Lange; Christian Griesinger; Michael Kolbe
Journal:  Nat Struct Mol Biol       Date:  2010-06-13       Impact factor: 15.369

5.  Characterization of the interaction between the Salmonella type III secretion system tip protein SipD and the needle protein PrgI by paramagnetic relaxation enhancement.

Authors:  Thenmalarchelvi Rathinavelan; Chun Tang; Roberto N De Guzman
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

6.  Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation.

Authors:  Da-Kang Shen; Saroj Saurya; Carolin Wagner; Hiroaki Nishioka; Ariel J Blocker
Journal:  Infect Immun       Date:  2010-10-11       Impact factor: 3.441

7.  The crystal structures of the Salmonella type III secretion system tip protein SipD in complex with deoxycholate and chenodeoxycholate.

Authors:  Srirupa Chatterjee; Dalian Zhong; Bryce A Nordhues; Kevin P Battaile; Scott Lovell; Roberto N De Guzman
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

8.  Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip.

Authors:  Kenneth F Stensrud; Philip R Adam; Cassandra D La Mar; Andrew J Olive; Gerald H Lushington; Raghavi Sudharsan; Naomi L Shelton; Richard S Givens; Wendy L Picking; William D Picking
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

9.  Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon.

Authors:  Nicholas E Dickenson; Shyamal P Choudhari; Philip R Adam; Ryan M Kramer; Sangeeta B Joshi; C Russell Middaugh; Wendy L Picking; William D Picking
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

10.  The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding.

Authors:  A Dorothea Roehrich; Isabel Martinez-Argudo; Steven Johnson; Ariel J Blocker; Andreas K J Veenendaal
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.